Rheumatology News and Research

RSS

Rheumatology is a sub-specialty in internal medicine and pediatrics, devoted to the diagnosis and therapy of rheumatic diseases. Rheumatologists mainly deal with clinical problems involving joints, soft tissues and allied conditions of connective tissues.

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.

8 Nov 2022

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that discontinuing methotrexate for one week after seasonal influenza vaccination provided the same seroprotection as a two-week discontinuation period in patients with rheumatoid arthritis.

8 Nov 2022

Combination treatment does not slow radiographic spinal progression in radiographic axSpA patients

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that combining a nonsteroidal anti-inflammatory drug and TNF inhibitor did not significantly slow radiographic spinal progression in radiographic axial spondyloarthritis patients.

8 Nov 2022

Lower hydroxychloroquine dosing results in increased SLE-related hospitalizations, study finds

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual scientific meeting, found that the recommended weight-based or non-weight-based dose of hydroxychloroquine led to more hospitalizations for flares among patients with systemic lupus erythematosus

8 Nov 2022

Spine disease in CRMO patients found to be more common than previously believed

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, shows that spine disease, once considered a rarity in chronic recurrent multifocal osteomyelitis, affects as many as 10-35% of patients and is asymptomatic in one-third.

8 Nov 2022

Study: No significant difference in cancer risk in rheumatology patients with history of malignancy taking DMARDs

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found no significant difference in cancer risk in patients with rheumatic disease and a history of malignancy taking biologic or targeted synthetic DMARDs compared to those treated with TNF inhibitors.

8 Nov 2022

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).

8 Nov 2022

Most echocardiography screenings for fetal congenital heart block fail to follow guidelines

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that most echocardiography screening for fetal congenital heart block in anti-Ro- and anti-La-positive pregnancies did not follow recommended guidelines in one academic medical center.

8 Nov 2022

ACR releases new guideline that offers recommendations for integrative approach to RA treatment

The American College of Rheumatology (ACR) released a summary of its new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis.

7 Nov 2022

Study estimates the quality of care for patients with long-term health conditions

The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.

4 Nov 2022

EULAR points-to-consider can guide diagnostic evaluation, treatment and monitoring of SAIDs

SAIDs are a group of multi-system disorders caused by dysfunction in the innate immune system. A number of these SAIDs are mediated by a cytokine called interleukin-1 (IL-1), including the cryopyrin-associated periodic syndromes (CAPS), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), mevalonate kinase deficiency (MKD), and deficiency of the IL-1 receptor antagonist (DIRA).

1 Nov 2022

Dietary components do not have impact on RMD outcomes

In 2022, EULAR - the European Alliance of Rheumatology Associations - published new recommendations regarding lifestyle behaviors and work participation to prevent progression of rheumatic and musculoskeletal diseases (RMDs).

1 Nov 2022

Standarized PedMSUS courses to help evaluate children with arthritis

Pediatric musculoskeletal ultrasound (PedMSUS) has great potential in the evaluation of children with arthritis, and since 2012 several PedMSUS courses have been endorsed by EULAR - The European Alliance of Rheumatology Associations.

28 Oct 2022

First guidance to optimize the use of PROMs for young people with inflammatory arthritis

PROMs aim to collect information on how a disease impacts key areas of a person's life, such as their quality of life, ability to do everyday activities, and their social or sexual health.

28 Oct 2022

New EULAR task force aims to help achieve gender equity in academic rheumatology

Evidence on gender equity in academic rheumatology in Europe is currently limited. This knowledge gap has a direct effect on the ability of professional bodies to improve gender equity.

28 Oct 2022

Updated EULAR recommendations for children with pedAIIRD

People with autoimmune or auto-inflammatory rheumatic diseases have an increased risk of infections. This can be due to the underlying disease itself, or may be caused by treatment with immunomodulating or immunosuppressive drugs.

28 Oct 2022

Unique gut bacteria could be responsible for triggering rheumatoid arthritis in at-risk people

Researchers at the University of Colorado School of Medicine have discovered that a unique bacteria found in the gut could be responsible for triggering rheumatoid arthritis (RA) in people already at risk for the autoimmune disease.

26 Oct 2022

RIT professor receives grant to investigate new therapeutic approaches for scleroderma

More collagen in the human body is not always good, and Karin Wuertz-Kozak is investigating how disease progresses because of the increase in this important protein.

25 Oct 2022

Scientists receive $8.297 NIH grant to continue funding a Center for Lupus Research

A multi-institutional team of scientists, led by researchers at Weill Cornell Medicine's Gale and Ira Drukier Institute for Children's Health, have received a five-year $8.297 grant to continue funding a Center for Lupus Research.

21 Oct 2022

EULAR points-to-consider offers support to improve healthy work participation of people with RMDs

Across Europe, people with RMDs are less able to work than people in the general population. One of the most common reasons is that people with RMDs often have pain caused by their disease.

20 Oct 2022

Rheumatology News and Research

Further Reading

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

Combination treatment does not slow radiographic spinal progression in radiographic axSpA patients

Lower hydroxychloroquine dosing results in increased SLE-related hospitalizations, study finds

Spine disease in CRMO patients found to be more common than previously believed

Study: No significant difference in cancer risk in rheumatology patients with history of malignancy taking DMARDs

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

Most echocardiography screenings for fetal congenital heart block fail to follow guidelines

ACR releases new guideline that offers recommendations for integrative approach to RA treatment

Study estimates the quality of care for patients with long-term health conditions

EULAR points-to-consider can guide diagnostic evaluation, treatment and monitoring of SAIDs

Dietary components do not have impact on RMD outcomes

Standarized PedMSUS courses to help evaluate children with arthritis

First guidance to optimize the use of PROMs for young people with inflammatory arthritis

New EULAR task force aims to help achieve gender equity in academic rheumatology

Updated EULAR recommendations for children with pedAIIRD

Unique gut bacteria could be responsible for triggering rheumatoid arthritis in at-risk people

RIT professor receives grant to investigate new therapeutic approaches for scleroderma

Scientists receive $8.297 NIH grant to continue funding a Center for Lupus Research

EULAR points-to-consider offers support to improve healthy work participation of people with RMDs

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News